18.1 C
New Delhi
December 2, 2021
PowerNews TV

There is no proof of COVID-19 relapse, reinfection among recovered, says ICMR

Amid fears of reinfection among recovered patients of COVID-19 in some states, the Indian Council of Medical Research (ICMR) has refuted such claims on Wednesday saying there is no such evidence so far.

The members when asked in a press meet that whether there is any truth to statements made by COVID-19 task forces in some states that a few recovering patients may have infected again, said that no incident has been reported to them and it is far from being authentic.

Even the Health Minister of Maharashtra Rajesh Tope had expressed concerns over the news in parts of the state where people have reported breathlessness and other problems after recovering from the virus infection.

A senior group member of the ICMR surveillance said there has been no evidence proving relapses. “To establish SARS-CoV-2 reinfection, one needs to show a positive live virus in a BSL-3 level lab. World over epidemiologists have a similar view,” said GiridharaBabu, a member of the ICMR’s surveillance team. He said the supposed cases of repeat infection from some states may be post-viral symptoms of Covid-19 that still need to be studied thoroughly.”

According to ShashikiranUmakanth, a clinical investigator of Covid-19, the SARS-CoV-2 virus seems to be persisting in some individuals for a longer duration.

“But after about a week or 10 days, we know it is no longer capable of spreading and causing infection in others. The commonly performed tests to diagnose Covid-19 can identify virus part virus particles, but cannot decipher if these particles are live or inactivated,” he told the media. As per latest data, the total cases of COVID-19 infections surged to 28,36,925, while the death toll climbed to 53,866 with 977 new fatalities being reported in a day.

Related posts

India throws cold water on proposal to test Sputnik-V vaccine


Russia ties up with Dr. Reddy’s Lab for phase-3 trials of Sputnik V vaccine


US mulls to distribute Pfizer COVID-19 vaccine in December


Leave a Comment